{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:35:33Z","timestamp":1782740133409,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","id.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.idc.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T02:18:38Z","timestamp":1501726718000},"page":"577-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inhaled Antibiotics for Ventilator-Associated Infections"],"prefix":"10.1016","volume":"31","author":[{"given":"Lucy B.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.idc.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMra0904124","article-title":"Hospital-acquired infections due to gram-negative bacteria","volume":"362","author":"Peleg","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/cc13775","article-title":"Ventilator-associated pneumonia in the ICU","volume":"18","author":"Kalanuria","year":"2014","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.idc.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"e000066","DOI":"10.1136\/bmjresp-2014-000066","article-title":"A\u00a0national survey of the diagnosis and management of suspected ventilator-associated pneumonia","volume":"1","author":"Browne","year":"2014","journal-title":"BMJ Open Respir Res"},{"issue":"21","key":"10.1016\/j.idc.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.idc.2017.05.006_bib6","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2016.16226","article-title":"Trend in ventilator-associated pneumonia rates between 2005 and 2013","volume":"316","author":"Metersky","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.idc.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1097\/01.CCM.0000181731.53912.D9","article-title":"Clinical and economic consequences of ventilator-associated pneumonia: a systematic review","volume":"33","author":"Safdar","year":"2005","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1473-3099(10)70258-9","article-title":"Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study","volume":"11","author":"Lambert","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkn162","article-title":"Guidelines for the management of hospital-acquired pneumonia in the UK: report of the Working Party on Hospital-acquired Pneumonia of the British Society for Antimicrobial Chemotherapy","volume":"62","author":"Masterton","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"103","key":"10.1016\/j.idc.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1183\/09059180.00010303","article-title":"Optimising the duration of antibiotic therapy for ventilator-associated pneumonia","volume":"16","author":"Chastre","year":"2007","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp0804651","article-title":"Antibiotic-resistant bugs in the 21st century\u2013a clinical super-challenge","volume":"360","author":"Arias","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ajhp\/62.1.39","article-title":"Use of colistin in the treatment of multiple-drug-resistant gram-negative infections","volume":"62","author":"Berlana","year":"2005","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.idc.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhin.2011.04.004","article-title":"Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteria","volume":"78","author":"Athanassa","year":"2011","journal-title":"J\u00a0Hosp Infect"},{"issue":"11","key":"10.1016\/j.idc.2017.05.006_bib16","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00134-012-2628-7","article-title":"Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients","volume":"38","author":"Athanassa","year":"2012","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.idc.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4187\/respcare.01556","article-title":"Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia","volume":"57","author":"Arnold","year":"2012","journal-title":"Respir Care"},{"issue":"11","key":"10.1016\/j.idc.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","article-title":"Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study","volume":"16","author":"Korbila","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.idc.2017.05.006_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc3020","article-title":"Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis","volume":"9","author":"Michalopoulos","year":"2005","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.idc.2017.05.006_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.rmed.2007.10.011","article-title":"Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study","volume":"102","author":"Michalopoulos","year":"2008","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.idc.2017.05.006_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.diagmicrobio.2007.01.008","article-title":"Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B","volume":"58","author":"Pereira","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2017.05.006_bib25","first-page":"226","article-title":"Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients","volume":"35","author":"Perez-Pedrero","year":"2011","journal-title":"Med Intensiva"},{"issue":"5","key":"10.1016\/j.idc.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1378\/chest.75.5.586","article-title":"Endotracheally administered antibiotics for gram-negative bronchopneumonia","volume":"75","author":"Klastersky","year":"1979","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.idc.2017.05.006_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1378\/chest.61.2.117","article-title":"Endotracheal gentamicin in bronchial infections in patients with tracheostomy","volume":"61","author":"Klastersky","year":"1972","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.idc.2017.05.006_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.65.6.650","article-title":"Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study","volume":"65","author":"Klastersky","year":"1974","journal-title":"Chest"},{"issue":"5551","key":"10.1016\/j.idc.2017.05.006_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/bmj.2.5551.543","article-title":"Gentamicin and colistin in chronic purulent bronchial infections","volume":"2","author":"Pines","year":"1967","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.idc.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJM197509042931003","article-title":"Aerosol polymyxin and pneumonia in seriously ill patients","volume":"293","author":"Feeley","year":"1975","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2017.05.006_bib31","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/cc8206","article-title":"Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia","volume":"13","author":"Luyt","year":"2009","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.idc.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.200210-1167OC","article-title":"Aerosol delivery and modern mechanical ventilation: in\u00a0vitro\/in\u00a0vivo evaluation","volume":"168","author":"Miller","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2017.05.006_bib33","first-page":"A326","article-title":"Amikacin aerosol achieves high tracheal aspirate concentrations in intubated mechanically ventilated patients with Gram-negative pneumonia: a pharmacokinetic study","volume":"175","author":"Niederman","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.idc.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MCP.0000000000000160","article-title":"Ventilator-associated infection: the role for inhaled antibiotics","volume":"21","author":"Palmer","year":"2015","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.idc.2017.05.006_bib35","first-page":"761","article-title":"Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum","volume":"132","author":"Mendelman","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.idc.2017.05.006_bib36","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/cc11357","article-title":"Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept","volume":"16","author":"Gil-Perotin","year":"2012","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.idc.2017.05.006_bib37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1378\/chest.108.4.1049","article-title":"Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation","volume":"108","author":"Inglis","year":"1995","journal-title":"Chest"},{"issue":"5418","key":"10.1016\/j.idc.2017.05.006_bib38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"issue":"Pt 2","key":"10.1016\/j.idc.2017.05.006_bib39","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1099\/mic.0.2006\/002519-0","article-title":"The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and motility","volume":"153","author":"Marr","year":"2007","journal-title":"Microbiology"},{"issue":"7","key":"10.1016\/j.idc.2017.05.006_bib40","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/CCM.0b013e31817c0f9e","article-title":"Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit","volume":"36","author":"Palmer","year":"2008","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.idc.2017.05.006_bib41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201312-2161OC","article-title":"Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit","volume":"189","author":"Palmer","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.idc.2017.05.006_bib42","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/cc5032","article-title":"Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.idc.2017.05.006_bib43","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/jac\/dkm385","article-title":"Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis","volume":"60","author":"Ioannidou","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2006.051","article-title":"Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study","volume":"8","author":"Hallal","year":"2007","journal-title":"Surg Infect (Larchmt)"},{"issue":"2","key":"10.1016\/j.idc.2017.05.006_bib45","first-page":"76","article-title":"Administration of tobramycin aerosols in patients with nosocomial pneumonia: a preliminary study","volume":"29","author":"Le Conte","year":"2000","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.idc.2017.05.006_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.34.2.269","article-title":"Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group","volume":"34","author":"Brown","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2017.05.006_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13054-015-0868-y","article-title":"Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"19","author":"Zampieri","year":"2015","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.idc.2017.05.006_bib48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/CCM.0000000000000771","article-title":"The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis","volume":"43","author":"Valachis","year":"2015","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.idc.2017.05.006_bib49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/cid\/cir934","article-title":"What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression","volume":"54","author":"Florescu","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2017.05.006_bib50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","article-title":"Colistin in the 21st century","volume":"22","author":"Nation","year":"2009","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2017.05.006_bib51","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archinte.1966.00290160026006","article-title":"Acute renal failure associated with sodium colistimethate treatment","volume":"118","author":"Elwood","year":"1966","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib52","first-page":"31","article-title":"Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis","volume":"56","author":"Duncan","year":"1973","journal-title":"Minn Med"},{"issue":"2","key":"10.1016\/j.idc.2017.05.006_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"issue":"5","key":"10.1016\/j.idc.2017.05.006_bib54","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/432583","article-title":"Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"41","author":"Kwa","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2017.05.006_bib55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1183\/09031936.00156906","article-title":"Ventilator-associated pneumonia due to colistin susceptible-only microorganisms","volume":"30","author":"Rios","year":"2007","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.idc.2017.05.006_bib56","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"Munoz-Price","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/ajrccm.162.1.9910071","article-title":"Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin","volume":"162","author":"Hamer","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.idc.2017.05.006_bib58","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2017.05.006_bib59","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.chest.2016.11.026","article-title":"A\u00a0randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-negative ventilator-associated pneumonia: IASIS Trial","volume":"151","author":"Kollef","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.idc.2017.05.006_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.idc.2017.05.006_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.201011-1894OC","article-title":"Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"184","author":"Lu","year":"2011","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552017300363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552017300363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:06:11Z","timestamp":1569974771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552017300363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0891552017300363"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2017.05.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled Antibiotics for Ventilator-Associated Infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}